In the present study, the results showed that T1DM led to the NOX1 and NOX2 increase in bone ECs and only NOX2 inhibitors induced significant therapeutic effects, with NOX2ds-tat and GSK2795039 showing high efficiency while VAS2870 was inefficient. Here, NOX1 is linked to type 1 diabetes mellitus.